Navigation Links
Spectrum Announces Fetal Bovine Serum Product Line
Date:7/24/2009

Spectrum now offers Fetal Bovine Serum (FBS) originating from abattoirs located in the US, Mexico, Canada, and Australia. In addition to untreated premium FBS, secondary treatments such as heat inactivation, dialysis, or gamma irradiation are available as standard catalog items. Spectrum also announced the availability of specialty pre-screened FBS for embryonic stem cell research. Each FBS order includes a full biochemical and chemical profile, as well as certification of the country of origin.

Gardena, CA (PRWEB) July 24, 2009 -- Spectrum Chemicals & Laboratory Products (Spectrum) announced the launch of a new line of premium quality Fetal Bovine Serum (FBS) ideal for many cell culture applications.

In partnership with an established biotechnology supplier, Spectrum now offers fetal bovine serum originating from abattoirs located in the US, Mexico, Canada, and Australia. Each FBS order includes a full biochemical and chemical profile, as well as certification of the country of origin. All of Spectrum's new serum products are in compliance with cGMP pharmaceutical standards, United States Department of Agriculture (USDA) guidelines, and the Food and Drug Administration (FDA) regulations.

In addition to untreated premium FBS, secondary treatments such as heat inactivation, dialysis, or gamma irradiation are available as standard catalog items. Spectrum also announced the availability of specialty pre-screened FBS for embryonic stem cell research. This serum is pre-tested for its ability to support the growth of undifferentiated colonies of embryonic stem cells so that additional testing at customer sites is minimized. Spectrum includes value-added services in support of their new FBS products, including a generous lot-reserve and sampling program.

"Spectrum is already a source for many of the reagents, lab supplies, and equipment used in cell culture applications, so it makes sense for us to offer a broad selection of growth media to enhance our position as a one-stop source for life science products", says Dr. Arnie Aistars, Chemicals Product Manager at Spectrum. He adds, "We are committed to increasing our profile in the life sciences and biotechnology markets and now have a great foundation on which to build".

About Spectrum Chemicals & Laboratory Products

Founded in 1971, Spectrum Chemicals & Laboratory Products manufacturers and distributes fine chemicals for production and laboratory facilities around the globe. All of Spectrum's worldwide facilities are ISO 9001 certified, and the California and New Jersey plants are FDA registered drug establishments and operate under current Good Manufacturing Practices (cGMP). For more information on Spectrum Chemicas & Laboratory Products, visit - http://www.SpectrumChemical.com.

###

Read the full story at http://www.prweb.com/releases/fetal-bovine-serum/stem-cell/prweb2670684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
3. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
4. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
5. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
6. Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
7. "Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science.
8. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
9. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
10. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spectrum Announces Fetal Bovine Serum Product Line
(Date:10/10/2017)... ... 10, 2017 , ... USDM Life Sciences , the ... sciences and healthcare industries, announces a presentation by Subbu Viswanathan and Jennifer Jaye ... GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach to achieving ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
(Date:10/5/2017)... (PRWEB) , ... October 05, 2017 , ... LabRoots ... and scientists from around the world, is giving back to cancer research with a ... October. , Now through October 31, shoppers can use promo code PinkRibbon to ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):